PT  - JOURNAL ARTICLE
AU  - Thompson, Daniel A
AU  - Abbasizanjani, Hoda
AU  - Fry, Richard
AU  - Marchant, Emily
AU  - Griffiths, Lucy
AU  - Akbari, Ashley
AU  - Hollinghurst, Joe
AU  - North, Laura
AU  - Lyons, Jane
AU  - Torabi, Fatemeh
AU  - Davies, Gareth
AU  - Gravenor, Mike B
AU  - Lyons, Ronan
TI  - Staff-Pupil SARS-CoV-2 Infection Pathways in Schools: A Population Level Linked Data Approach
AID  - 10.1101/2021.02.04.21251087
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.04.21251087
4099  - http://medrxiv.org/content/early/2021/02/08/2021.02.04.21251087.short
4100  - http://medrxiv.org/content/early/2021/02/08/2021.02.04.21251087.full
AB  - Background Better understanding of the role that children and school staff play in the transmission of SARS-CoV-2 is essential to guide policy development on controlling infection whilst minimising disruption to children’s education and wellbeing.Methods Our national e-cohort (n=500,779) study used anonymised linked data for pupils, staff and associated households linked via educational settings. We estimated the risk of testing positive for SARS-CoV-2 infection for staff and pupils over the period August - December 2020, dependent on measures of recent exposure to known cases linked to their educational settings.Results The total number of cases in a school was not associated with a subsequent increase in the risk of testing positive (Staff OR per case 0.92, 95%CI 0.85, 1.00; Pupils OR per case 0.98, 95%CI 0.93, 1.02). Amongst pupils, the number of recent cases within the same year group was significantly associated with subsequent increased risk of testing positive (OR per case 1.12, 95%CI 1.08 – 1.15). These effects were adjusted for a range of demographic covariates, and in particular any known cases within the same household, which had the strongest association with testing positive (Staff OR 39.86, 95%CI 35.01, 45.38, pupil OR 9.39, 95%CI 8.94 – 9.88).Conclusions In a national school cohort, the odds of staff testing positive for SARS-CoV-2 infection were not significantly increased in the 14-day period after case detection in the school. However, pupils were found to be at increased risk, following cases appearing within their own year group, where most of their contacts occur. Strong mitigation measures over the whole of the study period may have reduced wider spread within the school environment.What is knownWhat is knownEvidence of the role schools play in the transmission of SARS-CoV-2 is limitedHigher positivity rates are observed in school staff compared to pupilsLack of evidence on transmission pathways transmission into and within schoolsWhat this study addsWhat this study addsFirst UK national level study of transmission between pupils and staff in a school environment during the SARS-CoV-2 pandemic.Schools opening September-December 2020 was not associated with an increased subsequent risk of testing positive in staffPupils were found to be at increased risk of testing positive, following cases appearing within their own year groupCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Medical Research Council [MR/V028367/1]; Health Data Research UK [HDR-9006] which receives its funding from the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation (BHF) and the Wellcome Trust; and Administrative Data Research UK which is funded by the Economic and Social Research Council [grant ES/S007393/1].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The data used in this study are available in the SAIL Databank at Swansea University, Swansea, UK. All proposals to use SAIL data are subject to review by an independent Information Governance Review Panel (IGRP). Before any data can be accessed, approval must be given by the IGRP. The IGRP gives careful consideration to each project to ensure proper and appropriate use of SAIL data. When access has been approved, it is gained through a privacy-protecting safe haven and remote access system referred to as the SAIL Gateway. SAIL has established an application process to be followed by anyone who would like to access data via SAIL https://www.saildatabank.com/application-process. All research conducted in this study has been completed under the permission and approval of the SAIL independent Information Governance Review Panel (IGRP) project number 0911.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in this study are anonymised. Access to the data is available on application to the SAIL Databank (www.saildatabank.com). https://www.saildatabank.com